Outcomes of Selective Laser Trabeculoplasty as Initial Treatment for Glaucoma: A Retrospective Analysis from Enugu, Nigeria
Clinical Scorecard: Outcomes of Selective Laser Trabeculoplasty as Initial Treatment for Glaucoma: A Retrospective Analysis from Enugu, Nigeria
At a Glance
Category Detail
Condition Glaucoma Key Mechanisms Selective Laser Trabeculoplasty (SLT) improves aqueous humor outflow, reducing intraocular pressure (IOP). Target Population Patients with open-angle glaucoma, including primary open-angle glaucoma (POAG), juvenile open-angle glaucoma (JOAG), or normal-tension glaucoma (NTG). Care Setting The Eye Specialists Hospital, Enugu, Nigeria.
Key Highlights
SLT shows IOP reduction efficacy ranging from 6.9% to 38.9%. Better IOP control and lower treatment costs observed with SLT compared to topical medications. Over 80%-90% of patients maintain IOP reduction of 20% one year post-treatment. Guideline-Based Recommendations
Diagnosis
Assess glaucoma severity using Humphrey mean deviation values. Management
Consider SLT as a first-line treatment for POAG and ocular hypertension. Monitoring & Follow-up
Evaluate IOP at 3, 6, 9, 12, 18, 24, and 36 months post-SLT. Risks
Initial cost, equipment availability, and training deficiencies may hinder SLT implementation. Patient & Prescribing Data
Treatment-naïve patients with open-angle glaucoma.
SLT is gaining acceptance as a primary treatment option despite barriers.
Clinical Best Practices
Use SLT for managing primary open-angle glaucoma in treatment-naïve patients. Ensure proper follow-up and monitoring of IOP post-SLT. Related Resources & Content
